{"product_id":"aasld-the-live-meeting-2021","title":"AASLD The Live Meeting 2021","description":"\u003cdiv class=\"prod-title\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv id=\"block-pagetitle\"\u003e\n\u003ch1 class=\"product-title product_title entry-title\"\u003eAASLD The Live Meeting 2021\u003c\/h1\u003e\n\u003cp\u003eAASLD The Live Meeting 2021\u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDay 1\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAASLD-ASGE Endoscopy Course\u003c\/li\u003e\n\u003cli\u003eAASLD-ILTS Transplant Course\u003c\/li\u003e\n\u003cli\u003eAASLD-Japan Society of Hepatology Joint Symposium\u003c\/li\u003e\n\u003cli\u003eGeneral Hepatology Update\u003c\/li\u003e\n\u003cli\u003eHepatology Associates Course\u003c\/li\u003e\n\u003cli\u003ePostgraduate Course – Part I\u003c\/li\u003e\n\u003cli\u003ePostgraduate Course – Part II\u003c\/li\u003e\n\u003cli\u003ePG Course – Part III\u003c\/li\u003e\n\u003cli\u003eValue-based Medicine in Hepatology\u003c\/li\u003e\n\u003cli\u003eSocial Media Session\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDay 2\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003ePresidential Welcome and President’s Choice Lecture\u003c\/li\u003e\n\u003cli\u003e2021 Academic Debates\u003c\/li\u003e\n\u003cli\u003eAASLD Distinguished Awards\u003c\/li\u003e\n\u003cli\u003eAASLD-NASPGHAN Pediatric Symposium\u003c\/li\u003e\n\u003cli\u003eAlcohol-associated Liver Disease SIG\u003c\/li\u003e\n\u003cli\u003eCareer Development Workshop\u003c\/li\u003e\n\u003cli\u003eCholestatic and Autoimmune Liver Diseases SIG\u003c\/li\u003e\n\u003cli\u003eClinical Practice SIG\u003c\/li\u003e\n\u003cli\u003eHans Popper Basic Science State-of-the-Art Lecture\u003c\/li\u003e\n\u003cli\u003eHepatitis B SIG\u003c\/li\u003e\n\u003cli\u003eHepatitis C SIG\u003c\/li\u003e\n\u003cli\u003eHepatotoxicity SIG\u003c\/li\u003e\n\u003cli\u003eLiver Cancer SIG\u003c\/li\u003e\n\u003cli\u003eLiver Cell Biology SIG\u003c\/li\u003e\n\u003cli\u003eNonalcoholic Fatty Liver Disease SIG\u003c\/li\u003e\n\u003cli\u003eLiver Fibrosis SIG\u003c\/li\u003e\n\u003cli\u003eLiver Transplantation and Surgery SIG\u003c\/li\u003e\n\u003cli\u003ePatient Annual Forum and Meet \u0026amp; Greet Networking\u003c\/li\u003e\n\u003cli\u003ePediatric Liver Disorders and Acute on Chronic Liver Failure SIG Program – Part I\u003c\/li\u003e\n\u003cli\u003ePediatric Liver Disorders and Acute on Chronic Liver Failure SIG Program – Part II\u003c\/li\u003e\n\u003cli\u003ePortal Hypertension Clinical and Experimental SIG\u003c\/li\u003e\n\u003cli\u003ePractice Guidelines Workshop\u003c\/li\u003e\n\u003cli\u003ePublic Health – Health Care Delivery SIG\u003c\/li\u003e\n\u003cli\u003eThomas E. Starzl Transplant Surgery State-of-the-Art Lecture\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDay 3\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAASLD \u0026amp; AASLD Foundation Awards \u0026amp; Honors Ceremony\u003c\/li\u003e\n\u003cli\u003eCirrhosis Improving Quality through Patient Empowerment\u003c\/li\u003e\n\u003cli\u003eDiversity Workshop\u003c\/li\u003e\n\u003cli\u003eHBV Cures v2\u003c\/li\u003e\n\u003cli\u003eHBV Global Symposium\u003c\/li\u003e\n\u003cli\u003eHepatology Associates SIG\u003c\/li\u003e\n\u003cli\u003eHow Physician-Patient Partnerships Can Improve Liver Disease Care \u0026amp; Research\u003c\/li\u003e\n\u003cli\u003eParallel-1 Advances with Approved HBV Therapies\u003c\/li\u003e\n\u003cli\u003eParallel-2 Health Services and Public Health\u003c\/li\u003e\n\u003cli\u003eParallel-3 Metabolic and Genetic Disease\u003c\/li\u003e\n\u003cli\u003eParallel-4 COVID-19 Clinical\u003c\/li\u003e\n\u003cli\u003eParallel-5 Pediatric Hepatology Metabolic and Genetic Diseases\u003c\/li\u003e\n\u003cli\u003eParallel-6 Experimental and Translational Portal Hypertension and ACLF\u003c\/li\u003e\n\u003cli\u003eParallel-7 Immunosuppression, Outcomes, Complications\u003c\/li\u003e\n\u003cli\u003eParallel-8 HBV Cascade of Care, Natural History and Diagnostics\u003c\/li\u003e\n\u003cli\u003eParallel-9 COVID-19 Translational and Clinical\u003c\/li\u003e\n\u003cli\u003ePostgraduate Course Live Q\u0026amp;A Session\u003c\/li\u003e\n\u003cli\u003ePresidential Plenary- Liver Transplant\u003c\/li\u003e\n\u003cli\u003eTransplant Surgery Workshop Part I\u003c\/li\u003e\n\u003cli\u003eTransplant Surgery Workshop Part II\u003c\/li\u003e\n\u003cli\u003eWomen’s Health Program\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e\u003cstrong\u003eDay 4\u003c\/strong\u003e\u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eAASLD_ALEH Joint Symposium\u003c\/li\u003e\n\u003cli\u003eAASLD_ASGE Endoscopy Course- Live Q\u0026amp;A Session\u003c\/li\u003e\n\u003cli\u003eAASLD_ILTS Transplant Course- Live Q\u0026amp;A Session\u003c\/li\u003e\n\u003cli\u003eClinical Research Workshop – Part I\u003c\/li\u003e\n\u003cli\u003eClinical Research Workshop – Part II\u003c\/li\u003e\n\u003cli\u003eCOVID-19 and the Liver Symposium\u003c\/li\u003e\n\u003cli\u003eGrit, Grace, Gratitude, and Resilienc What You Wish Your Doctors Knew About You\u003c\/li\u003e\n\u003cli\u003eMaking an Impact Where You Are Patient Voices as a Vehicle for Change\u003c\/li\u003e\n\u003cli\u003eNutrition 101 for Patients with Chronic Liver Disease\u003c\/li\u003e\n\u003cli\u003ePanel Discussion Saving More Lives Forward from A Burden of Genius\u003c\/li\u003e\n\u003cli\u003eParallel-10- Diagnostics and Biomarkers of NAFLD\u003c\/li\u003e\n\u003cli\u003eParallel 11- Healthcare Quality and Access in Hepatology\u003c\/li\u003e\n\u003cli\u003eParallel 12- Donor and Allocation Issues, Living and Split Donor Liver Transplantation\u003c\/li\u003e\n\u003cli\u003eParallel 13- Novel HBV Therapies and Approaches\u003c\/li\u003e\n\u003cli\u003eParallel 14- Hepatitis C Oral Session\u003c\/li\u003e\n\u003cli\u003eParallel 15- Biomarkers and Therapeutics in Autoimmune and Cholestatic Diseases\u003c\/li\u003e\n\u003cli\u003eParallel 16- Experimental and Translational Advances in Alcohol-Associated Liver Disease\u003c\/li\u003e\n\u003cli\u003eParallel 17- NAFLD and NASH- Predicting Outcomes and Response to Interventions\u003c\/li\u003e\n\u003cli\u003eParallel 18- Mechanisms of Cholestatic Liver Injury\u003c\/li\u003e\n\u003cli\u003eParallel 19- Clinical Advances in Alcohol-Associated Liver Disease\u003c\/li\u003e\n\u003cli\u003eParallel 20- Hepatobiliary Neoplasia- Clinical Oral Session\u003c\/li\u003e\n\u003cli\u003eParallel 21- NAFLD and NASH- Clinical Trials of Novel Therapeutics\u003c\/li\u003e\n\u003cli\u003eParallel 22- Portal Hypertension- Risk Stratification and Treatment for Varices\u003c\/li\u003e\n\u003cli\u003eParallel 23- Cell and Molecular Biology\u003c\/li\u003e\n\u003cli\u003eParallel 24- Hepatobiliary Neoplasia- Experimental\u003c\/li\u003e\n\u003cli\u003eTranslational Oral SessionPresidential Plenary- Clinical and Translational\u003c\/li\u003e\n\u003cli\u003eViral Hepatitis Elimination Session\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cp\u003e\u003cstrong\u003eDay 5\u003c\/strong\u003e\u003c\/p\u003e\n\u003cp\u003e \u003c\/p\u003e\n\u003cul\u003e\n\u003cli\u003eBasic Science Debrief\u003c\/li\u003e\n\u003cli\u003eClinical Hepatology Debrief\u003c\/li\u003e\n\u003cli\u003eEmerging Trends Symposium\u003c\/li\u003e\n\u003cli\u003eHepatitis Debrief\u003c\/li\u003e\n\u003cli\u003eHyman J. Zimmerman Hepatotoxicity State-of-the-Art Lecture\u003c\/li\u003e\n\u003cli\u003eLeon Schiff State-of-the-Art Lecture\u003c\/li\u003e\n\u003cli\u003eNAFLD Debrief\u003c\/li\u003e\n\u003cli\u003eNAFLD Debrief 2\u003c\/li\u003e\n\u003cli\u003eParallel 25- Portal Hypertension Clinical\u003c\/li\u003e\n\u003cli\u003eParallel 26- Liver Fibrogenesis and Non-Parenchymal Cell Biology\u003c\/li\u003e\n\u003cli\u003eParallel 27- Diversity, Equity, and Inclusion in Liver Disease Care\u003c\/li\u003e\n\u003cli\u003eParallel 28- Gut Liver Axis and Microbiome\u003c\/li\u003e\n\u003cli\u003eParallel 29- NAFLD and NASH- Management and Outcomes in the Clinic\u003c\/li\u003e\n\u003cli\u003eParallel 30- Genomics and Precision Medicine\u003c\/li\u003e\n\u003cli\u003eParallel 31- Clinical_ Translational Research in Pediatric Hepatology\u003c\/li\u003e\n\u003cli\u003eParallel 32- Clinical Acute on Chronic Liver Failure\u003c\/li\u003e\n\u003cli\u003eParallel 33- Experimental Advances in NAFLD\u003c\/li\u003e\n\u003cli\u003eParallel 34- Basic Science Research in Pediatric Hepatology\u003c\/li\u003e\n\u003cli\u003eParallel 35- Viral Hepatitis Oral Session (Non-HBV, Non-HCV)\u003c\/li\u003e\n\u003cli\u003ePatient Debrief\u003c\/li\u003e\n\u003cli\u003ePractice Guidelines Debrief for Patients\u003c\/li\u003e\n\u003cli\u003ePresidential Plenary- Basic and Translational\u003c\/li\u003e\n\u003cli\u003eThe Liver Meeting Closing Remarks\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954647797858,"sku":"MED-AMB07479","price":65.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/AASLD-The-Live-Meeting-2021-scaled-768x768-1.jpg?v=1779381588","url":"https:\/\/meducourse.com\/products\/aasld-the-live-meeting-2021","provider":"Meducourse","version":"1.0","type":"link"}